Biological therapy reduces bowel disease severity

Over half of patients saw an improvement after being treated with biological therapies for inflammatory bowel disease (IBD), according to data from the first national report of biological therapies.

The report shows that 62% of adult patients and 73% of paediatric patients saw the severity of their disease decrease after 12 weeks of treatment with biological therapy. ‘Biological therapies’ is the collective term for two particular drugs – Infliximab (IFX) and Adalimumab (ADA). NICE recommends that these drugs are used for treatment of patients who have not responded to conventional therapy.

 

Latest Issues

IDSc Annual Conference 2024

Hilton Birmingham Metropole Hotel
26th - 27th November 2024

IV Forum 2024

Birmingham Conference & Events Centre (BCEC)
Wednesday 4th December 2024

The AfPP Roadshow - Leeds

TBA, Leeds
7th December 2024

The Fifth Annual Operating Theatres Show 2025

Kia Oval, London
11th March 2025, 9:00am - 4:00pm

Infection Prevention and Control 2025 Conference and Exhibition

The National Conference Centre, Birmingham
29th – 30th April 2025

Decontamination and Sterilisation 2025 Conference and Exhibition

The National Conference Centre, Birmingham
11th April 2025